Get those creative gears turning! The 2025 PBS KIDS Writer Contest is just around the corner!
Nominate an exceptional West Virginia teacher today!
On Demand
On Demand
Watch locally produced documentaries & more.
On Demand
On Demand
West Virginia Morning
Inside Appalachia
West Virginia Week
Mountain Stage
Us & Them
The Legislature Today
Send us your comments and questions.
Stream our board meetings.
Check out the latest WVPB news.
Sign up for our newsletter and get weekly updates.
Meet the WVPB staff.
WV Educational Broadcasting Authority, the WVPB Foundation, and the Friends of WVPB.
Come work with us!
Sponsor impactful and engaging media and entertainment.
Use your IRA to make a gift to WVPB.
Become a member with your gift of $1,000 or more.
The Medical Cannabis Advisory Board declined to enact a proposed cap on THC in medical cannabis products. Board members say they need more information before making a decision.
THC – short for tetrahydrocannabinol – is the main psychoactive component in cannabis.
The proposal, which originated from the board’s Health and Medical Workgroup, would cap THC content in medical cannabis products in West Virginia at 10 percent.
“Medical evidence today really has only supported the possibility of using THC potencies of 10 percent or less to help with any medical condition,” said Dr. James Berry, a psychiatrist and the leader of the Health and Medical Workgroup. “And at the same time, there has been a preponderance of evidence associating higher THC content with a number of public health concerns, such as suicide, psychosis, in addition, depression, anxiety, these sorts of things.”
Public comment at Thursday’s meeting questioned why the proposed cap was necessary. Many speakers said 10 percent THC would make medical marijuana ineffective for many patients and only create more problems.
“I can tell you as a practitioner in Southern California I do see problems with cannabis,” said Dr. Cody Peterson, a pediatric pharmacist. “The most problematic products I see are from the black market and setting THC limits, especially those THC limits well below the products that are currently available on the market and people are accustomed to will create more demand, more incentive, and more profitability in the illicit market and you create more issues than you’re intending to correct.”
Board member Jesse Forbes expressed the need for more information on the issue before taking it up again at a later date.
“I’ve got a suggestion that, with respect to recommendation number one, that the board not take action today,” Forbes said. “Ultimately, it’s the legislature that would do it, but that’s my suggestion is that we get some more data.”
The Medical Cannabis Advisory Board will meet again January 5.
